This company listing is no longer active
Spectral MD Holdings Croissance future
Future contrôle des critères 5/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Spectral MD Holdings.
Informations clés
79.2%
Taux de croissance des bénéfices
79.2%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 22.9% |
| Taux de croissance des recettes | 51.0% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 06 Sep 2023 |
Mises à jour récentes de la croissance future
Recent updates
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2025 | 119 | 34 | 31 | N/A | 2 |
| 12/31/2024 | 38 | -3 | -10 | -9 | 2 |
| 12/31/2023 | 26 | -10 | -6 | -6 | 2 |
| 3/31/2023 | 25 | -6 | -4 | -4 | N/A |
| 12/31/2022 | 25 | -3 | -1 | -1 | N/A |
| 9/30/2022 | 23 | -3 | -1 | -1 | N/A |
| 6/30/2022 | 20 | -4 | -2 | -2 | N/A |
| 3/31/2022 | 18 | -5 | -3 | -3 | N/A |
| 12/31/2021 | 15 | -5 | -3 | -3 | N/A |
| 9/30/2021 | 16 | -4 | 0 | 0 | N/A |
| 6/30/2021 | 17 | -3 | 2 | 2 | N/A |
| 3/31/2021 | 17 | -1 | 3 | 3 | N/A |
| 12/31/2020 | 17 | 1 | 4 | 4 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: SMD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.4%).
Bénéfices vs marché: SMD is forecast to become profitable over the next 3 years, which is considered above average market growth.
Croissance élevée des bénéfices: SMD is expected to become profitable in the next 3 years.
Chiffre d'affaires vs marché: SMD's revenue (51% per year) is forecast to grow faster than the UK market (4.1% per year).
Croissance élevée des revenus: SMD's revenue (51% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if SMD's Return on Equity is forecast to be high in 3 years time